GSK to sell remaining 4.2% stake in Haleon
Updated : 17:18
GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
The pharmaceutical company will sell about 385m ordinary shares in consumer health business Haleon, which it spun off in July 2022.
GSK initially retained a 12.9% stake in Haleon, but has since sold stakes in May 2023, October 2023 and January 2024.
The final disposal will be conducted through a placing of ordinary shares to institutional investors. GSK said the offer price will be determined by means of an accelerated bookbuild offering process which will start immediately.